Gausemycin Antibiotic Family Acts via Ca<sup>2+</sup>-Dependent Membrane Targeting-Reference-Cited by-同舟云学术

Gausemycin Antibiotic Family Acts via Ca²⁺-Dependent Membrane Targeting

Published:2024-02-16 Issue:4 Volume:87 Page:664-674
ISSN:0163-3864
Container-title:Journal of Natural Products
language:en
Short-container-title:J. Nat. Prod.

Author:

Kravchenko Tatyana V.¹²,Paramonov Alexander S.¹,Kudzhaev Arsen M.¹,Efimova Svetlana S.³,Khorev Alexey S.¹,Kudryakova Gulnara Kh.²,Ivanov Igor A.¹,Chistov Alexey A.¹^ORCID,Baranova Anna A.¹,Krasilnikov Maxim S.¹⁴,Lapchinskaya Olda A.²,Tyurin Anton P.¹,Ostroumova Olga S.³,Smirnov Ivan V.¹,Terekhov Stanislav S.¹^ORCID,Dontsova Olga A.¹⁴,Shenkarev Zakhar O.¹^ORCID,Alferova Vera A.¹^ORCID,Korshun Vladimir A.¹^ORCID

Affiliation:

1. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia

2. Gause Institute of New Antibiotics, B. Pirogovskaya 11, 119021 Moscow, Russia

3. Institute of Cytology of the Russian Academy of Sciences, Tikhoretsky Prospect 4, 194064 St. Petersburg, Russia

4. Department of Chemistry, Lomonosov Moscow State University, 1-3 Leninskie Gory, 119992 Moscow, Russia

Funder

Ministry of Science and Higher Education of the Russian Federation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jnatprod.3c00612

Reference31 articles.

1. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019

2. Microfluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity

3. Ultrahigh-throughput functional profiling of microbiota communities

4. A gold mine for drug discovery: Strategies to develop cyclic peptides into therapies

5. Discovery and development of surotomycin for the treatment of Clostridium difficile